| Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and … C Liu, A Bayer, SE Cosgrove, RS Daum, SK Fridkin, RJ Gorwitz, ... Clinical infectious diseases 52 (3), e18-e55, 2011 | 5073 | 2011 |
| Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart … LM Baddour, WR Wilson, AS Bayer, VG Fowler Jr, IM Tleyjeh, MJ Rybak, ... Circulation 132 (15), 1435-1486, 2015 | 2747 | 2015 |
| Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and … M Rybak, B Lomaestro, JC Rotschafer, R Moellering Jr, W Craig, ... American Journal of Health-System Pharmacy 66 (1), 82-98, 2009 | 2138 | 2009 |
| Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists … MJ Rybak, BM Lomaestro, JC Rotscahfer, RC Moellering Jr, WA Craig, ... Clinical infectious diseases 49 (3), 325-327, 2009 | 992 | 2009 |
| Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the … MJ Rybak, J Le, TP Lodise, DP Levine, JS Bradley, C Liu, BA Mueller, ... American Journal of Health-System Pharmacy 77 (11), 835-864, 2020 | 959 | 2020 |
| The pharmacokinetic and pharmacodynamic properties of vancomycin MJ Rybak Clinical Infectious Diseases 42 (Supplement_1), S35-S39, 2006 | 868 | 2006 |
| Outcomes Analysis of Delayed Antibiotic Treatment for Hospital-Acquired Staphylococcus aureus Bacteremia TP Lodise, PS McKinnon, L Swiderski, MJ Rybak Clinical infectious diseases 36 (11), 1418-1423, 2003 | 763 | 2003 |
| American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical … LM Baddour, WR Wilson, AS Bayer, VG Fowler, IM Tleyjeh, MJ Rybak, ... Circulation 132 (15), 1435-86, 2015 | 641 | 2015 |
| Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines … R Kullar, SL Davis, DP Levine, MJ Rybak Clinical infectious diseases 52 (8), 975-981, 2011 | 564 | 2011 |
| Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity MJ Rybak, BJ Abate, SL Kang, MJ Ruffing, SA Lerner, GL Drusano Antimicrobial agents and chemotherapy 43 (7), 1549-1555, 1999 | 518 | 1999 |
| Nephrotoxicity of vancomycin, alone and with an aminoglycoside MJ Rybak, LM Albrecht, SC Boike, PH Chandrasekar Journal of Antimicrobial Chemotherapy 25 (4), 679-687, 1990 | 497 | 1990 |
| In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and-resistant … MJ Rybak, E Hershberger, T Moldovan, RG Grucz Antimicrobial Agents and Chemotherapy 44 (4), 1062-1066, 2000 | 439 | 2000 |
| Impact of High-Inoculum Staphylococcus aureus on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin … KL LaPlante, MJ Rybak Antimicrobial agents and chemotherapy 48 (12), 4665-4672, 2004 | 356 | 2004 |
| Therapeutic monitoring of vancomycin in adults: summary of consensus recommendations from the American Society of Health‐System Pharmacists, the Infectious Diseases Society of … MJ Rybak, BM Lomaestro, JC Rotschafer, RC Moellering Jr, WA Craig, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (11 …, 2009 | 324 | 2009 |
| The importance of bactericidal drugs: future directions in infectious disease RW Finberg, RC Moellering, FP Tally, WA Craig, GA Pankey, EP Dellinger, ... Clinical infectious diseases 39 (9), 1314-1320, 2004 | 299 | 2004 |
| Pharmacodynamics of cefepime in patients with Gram-negative infections VH Tam, PS McKinnon, RL Akins, MJ Rybak, GL Drusano Journal of Antimicrobial Chemotherapy 50 (3), 425-428, 2002 | 284 | 2002 |
| Ceragenins: cholic acid-based mimics of antimicrobial peptides XZ Lai, Y Feng, J Pollard, JN Chin, MJ Rybak, R Bucki, RF Epand, ... Accounts of chemical research 41 (10), 1233-1240, 2008 | 268 | 2008 |
| Tigecycline: first of a new class of antimicrobial agents WE Rose, MJ Rybak Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (8 …, 2006 | 227 | 2006 |
| Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus … RL Akins, MJ Rybak Antimicrobial agents and chemotherapy 45 (2), 454-459, 2001 | 222 | 2001 |
| A quasi-experiment to study the impact of vancomycin area under the concentration-time curve-guided dosing on vancomycin-associated nephrotoxicity NA Finch, EJ Zasowski, KP Murray, RP Mynatt, JJ Zhao, R Yost, ... Antimicrobial agents and chemotherapy 61 (12), 10.1128/aac. 01293-17, 2017 | 221 | 2017 |
